Single-cell analyses reveal the therapeutic effects of ATHENA and its mechanism in a rhabdomyosarcoma patient

BACKGROUND: Whole-cell tumor vaccines tend to suffer from low immunogenicity. Our previous study showed that irradiated lung cancer cell vaccines in mouse models enhance antitumor efficacy by eliciting an intensive T cells response and improving immunogenicity. Based on these findings, we developed...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yujun, Wang, Ke, Zhou, Yanli, Zhuang, Xibing, Shao, Shali, Qiao, Fulu, Wang, Xiangdong, Zou, Xin, Qiao, Tiankui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745782/
https://www.ncbi.nlm.nih.gov/pubmed/36523982
http://dx.doi.org/10.3389/fonc.2022.1039145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745782/
https://www.ncbi.nlm.nih.gov/pubmed/36523982
http://dx.doi.org/10.3389/fonc.2022.1039145

Ejemplares similares